The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

Supermicro, Inc. a Total IT Solution Provider for AI/ML, HPC, Cloud, Storage, and 5G/Edge, is introducing a wide range of new systems which are fully optimized for edge and embedded workloads. Several ...

The FDA has approved ViiV/Johnson & Johnson’s Cabenuva long-acting HIV treatment in a long-awaited decision that can free patients from a daily dosing regimen to an injection taken every month.

LAWRENCEVILLE, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company focused on developing non-viral DNA-mediated immunotherapy and evaluating an adaptation of ...

Tackle HIV is a public awareness and education initiative led by Gareth Thomas in partnership with ViiV Healthcare with Terrence Higgins Trust as the charity partner, inspired by his own experience ...